vs

Side-by-side financial comparison of Evercore Inc. (EVR) and HAEMONETICS CORP (HAE). Click either name above to swap in a different company.

Evercore Inc. is the larger business by last-quarter revenue ($1.4B vs $1.3B, roughly 1.1× HAEMONETICS CORP). Evercore Inc. runs the higher net margin — 23.0% vs 7.3%, a 15.7% gap on every dollar of revenue. On growth, Evercore Inc. posted the faster year-over-year revenue change (100.3% vs 4.8%). Over the past eight quarters, HAEMONETICS CORP's revenue compounded faster (99.2% CAGR vs 42.2%).

Evercore Inc., formerly known as Evercore Partners, is a global independent investment banking advisory firm founded in 1995 by Roger Altman, David Offensend, and Austin Beutner. The firm has advised on over $4.7 trillion of merger, acquisition, and restructuring transactions since its founding.

Haemonetics Corporation is a global provider of blood and plasma supplies and services. The company was founded in Natick, Massachusetts by Dr. Allen (Jack) Latham in the 1970s.

EVR vs HAE — Head-to-Head

Bigger by revenue
EVR
EVR
1.1× larger
EVR
$1.4B
$1.3B
HAE
Growing faster (revenue YoY)
EVR
EVR
+95.5% gap
EVR
100.3%
4.8%
HAE
Higher net margin
EVR
EVR
15.7% more per $
EVR
23.0%
7.3%
HAE
Faster 2-yr revenue CAGR
HAE
HAE
Annualised
HAE
99.2%
42.2%
EVR

Income Statement — Q1 FY2026 vs Q4 FY2026

Metric
EVR
EVR
HAE
HAE
Revenue
$1.4B
$1.3B
Net Profit
$322.7M
$97.3M
Gross Margin
14.9%
Operating Margin
83.4%
Net Margin
23.0%
7.3%
Revenue YoY
100.3%
4.8%
Net Profit YoY
106.1%
-42.0%
EPS (diluted)
$7.20

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EVR
EVR
HAE
HAE
Q1 26
$1.4B
$1.3B
Q4 25
$1.3B
$339.0M
Q3 25
$1.0B
$327.3M
Q2 25
$838.0M
$321.4M
Q1 25
$699.0M
$330.6M
Q4 24
$979.5M
$348.5M
Q3 24
$738.4M
$345.5M
Q2 24
$693.4M
$336.2M
Net Profit
EVR
EVR
HAE
HAE
Q1 26
$322.7M
$97.3M
Q4 25
$204.0M
$44.7M
Q3 25
$144.6M
$38.7M
Q2 25
$97.2M
$34.0M
Q1 25
$146.2M
$58.0M
Q4 24
$140.4M
$37.5M
Q3 24
$78.4M
$33.8M
Q2 24
$73.8M
$38.4M
Gross Margin
EVR
EVR
HAE
HAE
Q1 26
14.9%
Q4 25
59.7%
Q3 25
59.5%
Q2 25
59.8%
Q1 25
58.4%
Q4 24
55.5%
Q3 24
54.2%
Q2 24
52.0%
Operating Margin
EVR
EVR
HAE
HAE
Q1 26
83.4%
Q4 25
24.2%
19.9%
Q3 25
20.8%
17.9%
Q2 25
18.0%
16.8%
Q1 25
16.0%
21.6%
Q4 24
21.8%
16.9%
Q3 24
16.7%
15.0%
Q2 24
15.9%
11.8%
Net Margin
EVR
EVR
HAE
HAE
Q1 26
23.0%
7.3%
Q4 25
15.7%
13.2%
Q3 25
13.8%
11.8%
Q2 25
11.6%
10.6%
Q1 25
20.9%
17.5%
Q4 24
14.3%
10.8%
Q3 24
10.6%
9.8%
Q2 24
10.6%
11.4%
EPS (diluted)
EVR
EVR
HAE
HAE
Q1 26
$7.20
Q4 25
$4.80
$0.95
Q3 25
$3.41
$0.81
Q2 25
$2.36
$0.70
Q1 25
$3.48
$1.17
Q4 24
$3.32
$0.74
Q3 24
$1.86
$0.66
Q2 24
$1.81
$0.74

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EVR
EVR
HAE
HAE
Cash + ST InvestmentsLiquidity on hand
$245.4M
Total DebtLower is stronger
$1.2B
Stockholders' EquityBook value
$796.3M
Total Assets
$2.4B
Debt / EquityLower = less leverage
1.53×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EVR
EVR
HAE
HAE
Q1 26
$245.4M
Q4 25
$3.0B
$363.4M
Q3 25
$2.4B
$296.4M
Q2 25
$1.7B
$292.9M
Q1 25
$1.4B
$306.8M
Q4 24
$2.4B
$320.8M
Q3 24
$1.8B
$299.3M
Q2 24
$1.7B
$344.4M
Total Debt
EVR
EVR
HAE
HAE
Q1 26
$1.2B
Q4 25
$1.2B
Q3 25
$1.2B
Q2 25
$1.2B
Q1 25
$1.2B
Q4 24
Q3 24
Q2 24
Stockholders' Equity
EVR
EVR
HAE
HAE
Q1 26
$796.3M
Q4 25
$2.0B
$911.5M
Q3 25
$1.8B
$849.2M
Q2 25
$1.7B
$882.3M
Q1 25
$1.5B
$820.8M
Q4 24
$1.7B
$906.9M
Q3 24
$1.6B
$878.9M
Q2 24
$1.5B
$905.4M
Total Assets
EVR
EVR
HAE
HAE
Q1 26
$2.4B
Q4 25
$5.4B
$2.5B
Q3 25
$4.4B
$2.4B
Q2 25
$3.7B
$2.5B
Q1 25
$3.3B
$2.5B
Q4 24
$4.2B
$2.5B
Q3 24
$3.6B
$2.5B
Q2 24
$3.3B
$2.5B
Debt / Equity
EVR
EVR
HAE
HAE
Q1 26
1.53×
Q4 25
1.34×
Q3 25
1.44×
Q2 25
1.39×
Q1 25
1.49×
Q4 24
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EVR
EVR
HAE
HAE
Operating Cash FlowLast quarter
$293.2M
Free Cash FlowOCF − Capex
$209.9M
FCF MarginFCF / Revenue
15.7%
Capex IntensityCapex / Revenue
2.5%
Cash ConversionOCF / Net Profit
3.01×
TTM Free Cash FlowTrailing 4 quarters
$417.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EVR
EVR
HAE
HAE
Q1 26
$293.2M
Q4 25
$807.5M
$93.6M
Q3 25
$560.9M
$111.3M
Q2 25
$437.7M
$17.4M
Q1 25
$-549.7M
$116.6M
Q4 24
$686.4M
$43.8M
Q3 24
$234.5M
$48.8M
Q2 24
$348.5M
$-27.4M
Free Cash Flow
EVR
EVR
HAE
HAE
Q1 26
$209.9M
Q4 25
$798.6M
$87.2M
Q3 25
$541.5M
$106.3M
Q2 25
$411.7M
$13.6M
Q1 25
$-569.3M
$100.9M
Q4 24
$673.1M
$35.2M
Q3 24
$226.6M
$39.4M
Q2 24
$340.7M
$-33.1M
FCF Margin
EVR
EVR
HAE
HAE
Q1 26
15.7%
Q4 25
61.6%
25.7%
Q3 25
51.8%
32.5%
Q2 25
49.1%
4.2%
Q1 25
-81.4%
30.5%
Q4 24
68.7%
10.1%
Q3 24
30.7%
11.4%
Q2 24
49.1%
-9.8%
Capex Intensity
EVR
EVR
HAE
HAE
Q1 26
2.5%
Q4 25
0.7%
1.9%
Q3 25
1.9%
1.5%
Q2 25
3.1%
1.2%
Q1 25
2.8%
4.7%
Q4 24
1.4%
2.5%
Q3 24
1.1%
2.7%
Q2 24
1.1%
1.7%
Cash Conversion
EVR
EVR
HAE
HAE
Q1 26
3.01×
Q4 25
3.96×
2.09×
Q3 25
3.88×
2.88×
Q2 25
4.50×
0.51×
Q1 25
-3.76×
2.01×
Q4 24
4.89×
1.17×
Q3 24
2.99×
1.44×
Q2 24
4.72×
-0.71×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

EVR
EVR

Advisory Fees (1)$1.2B89%
Commissions and Related Revenue$62.7M4%
Underwriting Fees$55.1M4%
Asset Management and Administration Fees (2)$23.7M2%
Other Revenue, net$15.4M1%

HAE
HAE

Segment breakdown not available.

Related Comparisons